You are viewing: Italy European Infection Control Market analysis

The Italy European Infection Control Market was valued at $970.5 Million in 2025 and projected to reach to $1306.5 Million by 2030, representing a compound annual growth rate of 6.1%. Italy's infection control market is positioned for steady growth as healthcare providers prioritize infection prevention and control measures across clinical settings.

Italy European Infection Control Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy European Infection Control Market Trends and Insights

  • This growth trajectory reflects Italy's increasing investment in healthcare infrastructure and heightened awareness of infection prevention protocols across hospitals, clinics, and long-term care facilities.
  • Italy's market expansion is driven by regulatory compliance requirements, aging population demographics, and post-pandemic emphasis on biosecurity measures. The Italian infection control sector encompasses disinfectants, sterilization equipment, personal protective equipment (PPE), and monitoring systems.
  • Italy's healthcare system, supported by both public and private institutions, continues to modernize infection control practices to meet European standards.
  • Between 2025 and 2030, Italy is expected to see sustained demand for advanced infection prevention technologies and consumables, particularly in response to evolving pathogenic threats and stricter hygiene regulations..

Key Market Statistics

  • CAGR (2025-2030) 6.1% CAGR
  • Market Size, 2025 ~USD 970.5 Million
  • Forecast, 2030 ~USD 1306.5 Million
  • Country Italy

Italy European Infection Control Market Overview

Market Valuation Growth :

Italy's infection control market is valued at USD 970.5 million in 2025 and is projected to reach USD 1,306.5 million by 2030, demonstrating robust expansion driven by healthcare modernization initiatives.

Steady CAGR Performance :

The Italian market is growing at a CAGR of 6.1% through 2030, slightly below the global average of 6.6%, reflecting a mature but consistently expanding healthcare sector with strong infection prevention adoption.

Healthcare Infrastructure Investment :

Italy's increasing investment in hospital modernization and long-term care facility upgrades is driving demand for advanced infection control solutions across public and private healthcare institutions.

Heightened Prevention Awareness :

Post-pandemic awareness has strengthened infection prevention protocols across Italian hospitals, clinics, and care facilities, creating sustained demand for disinfection, sterilization, and protective equipment solutions.

Italy European Infection Control Market Dynamics

  • The market benefits from Italy's aging population, increased healthcare spending, and regulatory compliance requirements that mandate robust infection control standards in hospitals and long-term care facilities.
  • Healthcare institutions are investing in advanced sterilization technologies, disinfection systems, and personal protective equipment to meet evolving safety standards. The forecast period through 2030 will see continued expansion driven by technological innovation in infection control products, rising awareness among healthcare professionals, and strengthened infection prevention policies.
  • Italian healthcare providers are increasingly adopting integrated infection control solutions and digital monitoring systems.
  • Market growth will be supported by both public healthcare system investments and private sector expansion, positioning Italy as a significant contributor to the broader European infection control market..

Related Ecosystem

Key Takeaways

  • Italy's infection control market reaches USD 970.5 million in 2025 with projected growth to USD 1,306.5 million by 2030.
  • Italy demonstrates a 6.1% CAGR, reflecting steady investment in healthcare infection prevention infrastructure.
  • Italy's aging population and regulatory compliance drive sustained demand for advanced disinfection and sterilization solutions.
  • Italy's market growth is supported by both public healthcare modernization and private sector adoption of infection control technologies.

European Infection Control Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment ENDOSCOPE REPROCESSING PRODUCTS (Product & Service)
Forecast Period 2025-2030
Growth Rate CAGR of 6.6% from 2025 to 2030
Largest Segment HOSPITALS & CLINICS (End User)
Market Size Base Year (Billions) ~USD 14.95 (2025)
Revenue Forecast (Billions) ~USD 20.58 (2030)
Segments Covered Product & Service, Type, Product Type, Formulation, Epa Classification, End User, Formulation Type, Epa Classification Type, End Users

Italy European Infection Control Market Report Segmentation

9 segment dimensions are covered across the global market.

By Product & Service

  • Cleaning & Disinfection Products
  • Endoscope Reprocessing Products
  • Other Infection Control Products
  • Protective Barriers
  • Sterilization Products & Services

By Type

  • Automated Endoscope Reprocessing Equipment
  • Biological Indicators
  • Chemical Indicators
  • Cleaners & Disinfectant Equipment
  • Consumables & Accessories
  • Contract Sterilization Services
  • Covers & Closures
  • Disinfectants
  • Disinfection & Cleaning Accessories
  • Dry Heat Sterilizers
  • E-Beam Sterilization Services
  • Endoscope Reprocessing Consumables
  • Endoscope Reprocessing Equipment & Solutions
  • Endoscope Tracking Solutions
  • Eto Sterilization Services
  • Eto Sterilizers
  • Face Masks
  • Flusher Disinfectors
  • Formaldehyde Sterilizers
  • Gamma Sterilization Services
  • Gloves
  • Goggles
  • Heat Sterilization Equipment
  • Hydrogen Peroxide Sterilizers
  • Low-Temperature Sterilization Equipment
  • Lubricants & Cleaning Solutions
  • Medical Nonwovens
  • Moist Heat Sterilizers
  • Other Cleaning & Disinfection Equipment
  • Other Contract Sterilization Services
  • Other Endoscope Reprocessing Equipment
  • Other Low-Temperature Sterilizers
  • Radiation Sterilization Equipment
  • Steam Sterilization Services
  • Sterilization Accessories
  • Sterilization Equipment
  • Sterilization Indicators
  • Sterilization Lubricants
  • Sterilization Pouches
  • Surgical Drapes
  • Surgical Gowns
  • Ultrasonic Cleaners
  • Uv Disinfectors
  • Washer Disinfectors

By Product Type

  • Hand Disinfectants
  • Instrument Disinfectants
  • Skin Disinfectants
  • Surface Disinfectants

By Formulation

  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

By Epa Classification

  • High-Level Disinfectants
  • Intermediate-Level Disinfectants
  • Low-Level Disinfectants

By End User

  • Food Industry
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Other End Users
  • Pharmaceutical Companies

By Formulation Type

  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

By Epa Classification Type

  • High-Level Disinfectants
  • Intermediate-Level Disinfectants
  • Low-Level Disinfectants

By End Users

  • Food Industry
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Other End Users
  • Pharmaceutical Companies

Target Audience

  • Medical Device Manufacturers : Manufacturers of infection control products, sterilization equipment, and disinfection systems need Italy-specific market data to assess market size, growth potential, and competitive opportunities for product launches and market expansion.
  • Healthcare Facility Administrators : Hospital and clinic administrators require market insights to benchmark infection control spending, identify emerging solutions, and justify capital investments in infection prevention infrastructure and protocols.
  • Pharmaceutical & Biotech Companies : Companies developing antimicrobial agents, antiseptics, and infection control pharmaceuticals need Italy market analysis to understand demand drivers, regulatory pathways, and commercial opportunities in Italian healthcare.
  • Healthcare Consultants & Advisors : Management consultants and healthcare advisors serving Italian clients require detailed market data to support strategic planning, due diligence, and investment recommendations in the infection control sector.
  • Investors & Private Equity Firms : Investment professionals evaluating healthcare sector opportunities in Italy need comprehensive market sizing and growth forecasts to assess portfolio companies, identify acquisition targets, and evaluate market attractiveness.

Reasons to Buy this Report

  • Country-Specific Market Sizing : Obtain precise valuation data for Italy's infection control market with verified 2025 baseline (USD 970.5M) and 2030 forecast (USD 1,306.5M), enabling accurate budget allocation and revenue projections for Italian operations.
  • Competitive Landscape Intelligence : Understand Italy-specific market dynamics, competitive positioning, and growth drivers unique to Italian healthcare institutions, hospitals, and long-term care facilities to inform market entry or expansion strategies.
  • Regulatory & Compliance Insights : Access Italy-specific infection control regulations, healthcare compliance requirements, and institutional standards that influence product adoption and purchasing decisions across Italian healthcare providers.
  • Growth Opportunity Identification : Identify high-potential segments within Italy's 6.1% CAGR growth trajectory, including emerging technologies, underserved regions, and facility types with accelerating infection control investment needs.
  • Strategic Decision Support : Leverage Italy-focused market analysis to support partnership development, distribution agreements, product localization, and investment decisions within the Italian healthcare infection control sector.

Frequently asked questions

What is the current size of Italy's infection control market?

Italy's infection control market is valued at USD 970.5 million in 2025.

What is the projected market size for Italy by 2030?

Italy's infection control market is projected to reach USD 1,306.5 million by 2030.

What is the CAGR for Italy's infection control market?

Italy's infection control market is expected to grow at a CAGR of 6.1% from 2025 to 2030.

What factors are driving growth in Italy's infection control market?

Italy's market growth is driven by regulatory compliance requirements, an aging population, post-pandemic biosecurity emphasis, and modernization of healthcare infrastructure.

Which segments comprise Italy's infection control market?

Italy's infection control market includes disinfectants, sterilization equipment, personal protective equipment (PPE), and monitoring systems.

RESEARCH METHODOLOGY

The study involved primary activities in estimating the current market size for the European infection control market. Exhaustive secondary research was done to collect information on the European infection control industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the European infection control market.

The four steps involved in estimating the market size are:

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases, white papers, annual reports, investor presentations, SEC filings of companies, and publications from government sources [such as the US FDA, World Health Organization (WHO), CDC, ISO, Agency for Healthcare Research and Quality] were referred to identify and collect information for the European infection control market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the European infection control market. The primary sources from the demand side include Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

The following is a breakdown of the primary respondents:

European Infection Control Market

Note 1: Other designations include sales, marketing, and product & service managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the market value, annual revenues were calculated based on the revenue mapping of leading product & service manufacturers and OEMs active in the European infection control market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The European infection control market was split into various segments and sub-segments based on:

  • List of major players operating in the products & services market at the regional and/or country level
  • Products & service mapping of European infection control providers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from European infection control (or the nearest reported business unit/products & services category)
  • Extrapolation of the revenue mapping of the listed major players to derive the market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the European infection control market

The above data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

The research methodology used to estimate the market size includes the following:

European Infection Control Market

Data Triangulation

The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Infection control refers to eliminating all forms of microorganisms from objects and surfaces to ensure sterility of the object/surface, making it suitable for human use/reuse and avoiding contamination and the spread of diseases. The infection control market for products & services used for cleaning, disinfecting, and sterilizing objects/surfaces in hospitals & clinics, medical device companies, pharmaceutical companies, and the food & life science industries.

Stakeholders

  • European infection control product & service manufacturers
  • European infection control vendors & distributors
  • Hospitals
  • Clinical & diagnostic laboratories
  • Pharmaceutical & biopharmaceutical companies
  • Venture capitalists & investors

Report Objectives

  • To define, describe, analyze, and forecast the European infection control (LFA) market by product & service, end user, and countries
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets concerning individual growth trends, prospects, and contributions to the overall European infection control market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning European countries
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product & service excellence
  • To study the impact of AI/Generative AI on the market, along with the macroeconomic outlook for each region

Get the Full European Infection Control Market Report

Full forecast, segment splits, and company analysis for all European Infection Control Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status